Cite
Integrin β[sub 3] Leu33Pro Homozygosity and Risk of Cancer.
MLA
Bojesen, Stig E., et al. “Integrin β[Sub 3] Leu33Pro Homozygosity and Risk of Cancer.” JNCI: Journal of the National Cancer Institute, vol. 95, no. 15, Aug. 2003, pp. 1150–57. EBSCOhost, https://doi.org/10.1093/jnci/djg005.
APA
Bojesen, S. E., Tybjærg-Hansen, A., & Nordestgaard, B. G. (2003). Integrin β[sub 3] Leu33Pro Homozygosity and Risk of Cancer. JNCI: Journal of the National Cancer Institute, 95(15), 1150–1157. https://doi.org/10.1093/jnci/djg005
Chicago
Bojesen, Stig E., Anne Tybjærg-Hansen, and Børge G. Nordestgaard. 2003. “Integrin β[Sub 3] Leu33Pro Homozygosity and Risk of Cancer.” JNCI: Journal of the National Cancer Institute 95 (15): 1150–57. doi:10.1093/jnci/djg005.